{
 "episode_id": "all-in-2026-06-09-bill-maris-how-google-could-crush-ai-competitors-why-small-f",
 "title": "Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI's Atari Stage",
 "podcast": "all-in",
 "published_at": "2026-06-09",
 "speakers": [
  "Bill Maris",
  "Chamath Palihapitiya",
  "Jason Calacanis",
  "David Friedberg",
  "David Sacks"
 ],
 "summary": "Bill Maris, founder of Section 32 and former founding CEO of Google Ventures, delivers a keynote at an All-In event tracing four lessons from his career: glimpsing the future through unconventional signals, embracing apparent insanity as a founder, trusting computer science, and the math behind small-fund outperformance. He argues Google could weaponize token pricing to crush OpenAI and Anthropic, that AI is currently at an 'Atari stage' and will reach 'PlayStation 10' within five years via infrastructure — not bigger models — and that late-stage mega-IPOs are being priced unfairly onto public retirement accounts. A short panel discussion covers venture incentive structures, the biotech renaissance, and the risks of the US losing scientific talent to China.",
 "topics": [
  {
   "name": "Keynote intro and origin story: Vermont data center",
   "timestamp": "0:15",
   "summary": "Maris recounts founding a web hosting and data center company in 1997 from his Vermont apartment, using the leaking-roof-tarring-in-a-thunderstorm anecdote as a metaphor for the apparent insanity required to see the future."
  },
  {
   "name": "Lesson 1 — Glimpsing the future through a keyhole",
   "timestamp": "0:15",
   "summary": "Maris describes how seeing a server in an office closet in 1997 triggered his conviction about the internet, and frames the pattern of entrepreneurs knowing a secret about the future that others don't believe."
  },
  {
   "name": "Lesson 2 — Insanity as a feature of founders",
   "timestamp": "0:15",
   "summary": "Using the Stuart Butterfield inauguration photo series (1989, 2005, 2009) Maris illustrates how innovators appear insane to peers but are simply seeing ahead."
  },
  {
   "name": "Lesson 3 — Don't bet against computer science: GV founding and machine learning portfolio construction",
   "timestamp": "0:15",
   "summary": "Maris describes founding Google Ventures in 2007, using machine learning to design portfolio construction and optimal fund size via millions of simulations; GV returned ~4.1x overall, with Maris-led investments performing above that."
  },
  {
   "name": "Lesson 4 — Small funds outperform large funds (the math)",
   "timestamp": "0:15",
   "summary": "Maris presents data showing top-decile DPI for funds under $750M averaged 476x vs. 242x for funds over $1B, with 95% of top-decile performers below $750M, and walks through the return-math that makes large funds structurally unable to generate top-decile returns."
  },
  {
   "name": "Google as an AI price weapon: could it crush OpenAI and Anthropic?",
   "timestamp": "13:25",
   "summary": "Maris argues that if Google arbitrarily cut token prices by 80%, OpenAI and Anthropic business models would go 'super critical'; the panel debates whether this is inevitable, and the distinction between margin compression and VC-funded price wars."
  },
  {
   "name": "Late-stage mega-IPOs and fairness to retail/401K holders",
   "timestamp": "16:09",
   "summary": "Maris critiques companies that wrap themselves in public-benefit language while keeping value creation private and then offloading onto passive/ETF buyers; he questions whether SpaceX and Anthropic can justify public-market valuations by discounted cash flows."
  },
  {
   "name": "AI's Atari stage and the infrastructure investment thesis",
   "timestamp": "19:10",
   "summary": "Maris uses the gaming-industry analogy (Zork→PlayStation) to argue AI will transform radically within five years, but the value will be captured in platforms and infrastructure (physics engines, controllers, GPUs), not larger models."
  },
  {
   "name": "Life sciences, biotech, and the US brain-drain risk",
   "timestamp": "21:03",
   "summary": "Maris discusses his interest in computational biology and longevity (Calico, New Limit), tempers expectations on FDA timelines, and warns that gutting of NIH/CDC plus H1B restrictions is driving scientific talent to China."
  },
  {
   "name": "Panel: venture fund size and incentive structures",
   "timestamp": "25:30",
   "summary": "Sacks and Maris debate whether late-stage 'sniper' investing is viable long-term; Maris dissects the broken incentive loops for LPs, GPs, and entrepreneurs that bias the industry toward oversized funds despite inferior returns."
  }
 ],
 "entities": [
  {
   "name": "Bill Maris",
   "type": "person",
   "salience": "central",
   "role_in_episode": "Guest speaker; founder of Section 32 and GV; delivers the keynote and drives the core theses on fund size, Google price war, and AI infrastructure."
  },
  {
   "name": "Section 32",
   "type": "company",
   "salience": "central",
   "role_in_episode": "Maris's current fund; six funds averaging $400M, all top-decile, used as the proof point for small-fund outperformance."
  },
  {
   "name": "Google Ventures",
   "type": "company",
   "salience": "central",
   "role_in_episode": "Fund Maris founded in 2007 at Google; returned ~4.1x overall; the GV origin story anchors lessons 3 and 4."
  },
  {
   "name": "Google",
   "type": "company",
   "salience": "central",
   "role_in_episode": "Hypothetical price-war aggressor; Maris argues it could cut token prices 80% and crush OpenAI/Anthropic."
  },
  {
   "name": "OpenAI",
   "type": "company",
   "salience": "central",
   "role_in_episode": "Primary target in the Google token price-war scenario; its business model is argued to be vulnerable to commodity pricing."
  },
  {
   "name": "Anthropic",
   "type": "company",
   "salience": "central",
   "role_in_episode": "Secondary target in the Google price-war scenario; also named as an example of a private company staying private too long at the expense of retail investors."
  },
  {
   "name": "Gemini",
   "type": "product",
   "salience": "discussed",
   "role_in_episode": "Google's AI product cited as the vehicle through which Google could undercut OpenAI/Anthropic pricing."
  },
  {
   "name": "David Sacks",
   "type": "person",
   "salience": "discussed",
   "role_in_episode": "All-In host; discusses fund size and strategy in the panel segment."
  },
  {
   "name": "Chamath Palihapitiya",
   "type": "person",
   "salience": "discussed",
   "role_in_episode": "All-In host; probes the Google price-war scenario and critiques companies keeping value from retail investors."
  },
  {
   "name": "David Friedberg",
   "type": "person",
   "salience": "discussed",
   "role_in_episode": "All-In host; asks about venture bimodality and the AI-driven biotech renaissance."
  },
  {
   "name": "venture capital fund size",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "The episode's central analytical thesis: small funds structurally outperform large funds, supported with DPI data."
  },
  {
   "name": "AI infrastructure",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "Maris's investment thesis: the next wave of AI value is in platforms, physics engines, and controllers — not bigger models."
  },
  {
   "name": "token pricing",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "The mechanism by which Google could price-war OpenAI/Anthropic into unsustainability."
  },
  {
   "name": "SpaceX",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Named as an example of a private mega-cap whose lockup and IPO valuation dynamics are questionable for public investors."
  },
  {
   "name": "Calico",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Longevity company Maris incubated at Google; cited as early evidence of his interest in life sciences."
  },
  {
   "name": "New Limit",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Blake Byers and Brian Armstrong's longevity company; a current Section 32 portfolio investment."
  },
  {
   "name": "Waymo",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Self-driving company Maris incubated at Google; cited as an example of his VP Special Projects work."
  },
  {
   "name": "Andreessen Horowitz",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Implicit benchmark large fund; Chamath asks whether Sacks should 'become Andreessen Horowitz' — the archetype of large-fund VC."
  },
  {
   "name": "CrowdStrike",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Section 32 portfolio company cited as a successful exit example."
  },
  {
   "name": "Cohere",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Section 32 portfolio company cited as a successful example."
  },
  {
   "name": "Coinbase",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "Section 32 portfolio company cited as a successful example."
  },
  {
   "name": "Climate Corp",
   "type": "company",
   "salience": "mentioned",
   "role_in_episode": "First ex-Google company GV invested in (at Jason's company); sold to Monsanto for $1B."
  },
  {
   "name": "NIH",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "Named as a US scientific institution being defunded, contributing to brain-drain risk."
  },
  {
   "name": "CDC",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "Named alongside NIH as a US scientific institution being gutted, contributing to talent exodus."
  },
  {
   "name": "computational biology",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "An area Maris is actively investing in; distinguished from therapeutic/clinical-trial biotech which he avoids."
  },
  {
   "name": "longevity",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Maris's long-standing interest; Calico and New Limit are his vehicles in this space."
  }
 ],
 "claims": [
  {
   "holder": "Bill Maris",
   "claim": "If Google arbitrarily cut token prices by 80%, the business models of OpenAI and Anthropic would go super critical.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "Google",
    "OpenAI",
    "Anthropic",
    "token pricing"
   ],
   "timestamp": "13:25",
   "quote": "if you're a company and you can go to Google on Gemini and you can pay 80% less for that basically identical product, why wouldn't you do that? Then the compression and the pressure on those other businesses goes super critical."
  },
  {
   "holder": "Bill Maris",
   "claim": "If he were Google, cutting token prices to undercut competitors is exactly what he would do.",
   "stance": "opinion",
   "conviction": 0.85,
   "subjects": [
    "Google",
    "token pricing"
   ],
   "timestamp": "15:22",
   "quote": "If I were Google, that's what I'd do."
  },
  {
   "holder": "Chamath Palihapitiya",
   "claim": "Google cutting token prices aggressively to destroy competitor margins is not just possible but 100% probable.",
   "stance": "assertion",
   "conviction": 0.95,
   "subjects": [
    "Google",
    "token pricing",
    "OpenAI",
    "Anthropic"
   ],
   "timestamp": "16:06",
   "quote": "That's 100 percent possible. It's 100 percent probable."
  },
  {
   "holder": "Bill Maris",
   "claim": "Companies spending a trillion dollars with $60B in revenue and then relying on retail investors to absorb that at IPO is financially risky and ethically questionable.",
   "stance": "opinion",
   "conviction": 0.8,
   "subjects": [
    "OpenAI",
    "Anthropic",
    "SpaceX"
   ],
   "timestamp": "16:09",
   "quote": "a trillion for spend commitments on $60 billion of revenue. Now, you're going to go to the public and hope that retail is going to pick that up?"
  },
  {
   "holder": "Bill Maris",
   "claim": "Companies that wrap themselves in public-benefit language while keeping value creation private and then offloading risk onto public retirement accounts are being hypocritical.",
   "stance": "opinion",
   "conviction": 0.85,
   "subjects": [
    "OpenAI",
    "Anthropic",
    "venture capital fund size"
   ],
   "timestamp": "13:25",
   "quote": "I also have an observation that a bit of an objection to companies that wrap themselves up in public benefit language and then keep the value creation to themselves and an elite group of investors through a big part of the curve and then say, well, we're here to benefit humanity."
  },
  {
   "holder": "Bill Maris",
   "claim": "Passive funds and ETFs holding public retirement assets will be forced to buy overpriced mega-cap tech IPOs, making 401K holders the bag holders.",
   "stance": "assertion",
   "conviction": 0.75,
   "subjects": [
    "SpaceX",
    "Anthropic",
    "OpenAI"
   ],
   "timestamp": "16:30",
   "quote": "The passive funds, the ETFs are going to have to pick them up."
  },
  {
   "holder": "Bill Maris",
   "claim": "AI is currently at an 'Atari command line stage' and will reach a 'PlayStation 10 stage' within the next five years.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "AI infrastructure"
   ],
   "timestamp": "20:48",
   "quote": "We're at the Atari command line stage of AI, and we're going to get to the PlayStation 10 stage in the next five years."
  },
  {
   "holder": "Bill Maris",
   "claim": "The next wave of AI value will be captured by infrastructure platforms — physics engines, controllers, GPUs — not by bigger models.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "AI infrastructure"
   ],
   "timestamp": "19:10",
   "quote": "I don't plan on investing in larger models. It wasn't better stories that would make better games. It was controllers and physics engines and GPUs, and those are the parts of the AI cycle that I'm interested in"
  },
  {
   "holder": "Bill Maris",
   "claim": "Small funds (under ~$750M) structurally outperform large funds — this is math, not opinion.",
   "stance": "assertion",
   "conviction": 0.95,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "0:15",
   "quote": "small funds outperform large funds. This is simply the math. This is not an opinion I'm trying to convince you of."
  },
  {
   "holder": "Bill Maris",
   "claim": "A $7 billion fund needs to return $210 billion of exit value to achieve 3x — which exceeds total venture-backed M&A and IPO exit value in most years, making top-decile performance mathematically implausible at that scale.",
   "stance": "fact_cited",
   "conviction": 0.95,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "0:15",
   "quote": "if you have a $7 billion fund, and we do the same math through, you've got to return $210 billion, $7 billion to 70 times 3X is $210 billion, which exceeds the total venture-backed M&A and IPO exit value in most years."
  },
  {
   "holder": "Bill Maris",
   "claim": "The GP incentive structure in large funds is broken: a GP with a $5B fund returning 1.01x will earn more money than one with a $500M fund returning 3x.",
   "stance": "assertion",
   "conviction": 0.9,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "26:45",
   "quote": "if I have a $5 billion fund, I return 1.01x, I'm going to make more money than Bill with his $500 million fund that returns 3x."
  },
  {
   "holder": "Bill Maris",
   "claim": "Large funds distort valuations by forcing entrepreneurs to accept inflated pre-money valuations (e.g., $4B instead of $100M) so the fund can deploy capital, breaking the early-stage investment model.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "26:45",
   "quote": "Giant Fund Y says, well, we have this giant fund. We need to put $250 million in. And then entrepreneur says, well, but my company's valuation is $100. No, your valuation is now $4 billion."
  },
  {
   "holder": "Bill Maris",
   "claim": "Late-stage 'sniper' investing — waiting for breakouts and writing $50M checks — is not a viable long-term strategy; the data does not support it.",
   "stance": "opinion",
   "conviction": 0.75,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "26:45",
   "quote": "I don't think just staying late stage and waiting to sniper at larger companies will be a long term. The data would suggest that's not going to work in the long term."
  },
  {
   "holder": "Bill Maris",
   "claim": "Using AI (machine learning) for portfolio construction and fund-size optimization at GV was the right approach; the investments Maris personally led outperformed the overall 4.1x GV return.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "Google Ventures"
   ],
   "timestamp": "0:15",
   "quote": "I adhered more closely to the strategy and the investments that I led, and the investments that I led turned out like this"
  },
  {
   "holder": "Bill Maris",
   "claim": "The current anti-science environment in the US — gutting of NIH/CDC and H1B restrictions — is driving scientific talent to China, which is bad for US science.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "NIH",
    "CDC"
   ],
   "timestamp": "23:04",
   "quote": "the gutting of the CDC and the NIH and an anti-science vibe that has now pervades this country has driven a lot of mindshare elsewhere as funding is drying up for basic research."
  },
  {
   "holder": "Bill Maris",
   "claim": "H1B restrictions are making it easier for scientific talent to go elsewhere, and this is not good for American science.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "NIH"
   ],
   "timestamp": "24:15",
   "quote": "the pushing out of H1B holders, there's so much happening now that it's causing... It's just easier to go elsewhere. That's not good for science."
  },
  {
   "holder": "Bill Maris",
   "claim": "In biotech, finding a compound is only about 5% of the work due to FDA safety testing requirements, so therapeutic biotech will not progress as exponentially as hoped.",
   "stance": "opinion",
   "conviction": 0.75,
   "subjects": [
    "computational biology",
    "longevity"
   ],
   "timestamp": "22:06",
   "quote": "if you find a compound and you think you've got something, that's like 5 percent of the work. Where there's still all kinds of titrating and safety testing that needs to go on. So I don't think it's going to go quite as exponential as we would all like it to."
  },
  {
   "holder": "Bill Maris",
   "claim": "If we can achieve a realistic simulation of a human cell in silico, biotech progress will accelerate significantly.",
   "stance": "prediction",
   "conviction": 0.7,
   "subjects": [
    "computational biology"
   ],
   "timestamp": "22:06",
   "quote": "if we can achieve a realistic simulation of a human cell in Silico, then you will see that accelerate as well. We're not quite there yet."
  },
  {
   "holder": "Bill Maris",
   "claim": "The 75th percentile of venture funds loses money, and top-quartile performance is persistent, making the bar for LP allocations extremely high.",
   "stance": "fact_cited",
   "conviction": 0.9,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "0:15",
   "quote": "the 75th percentile of venture loses money and there is persistence of performance of the top quartile."
  },
  {
   "holder": "Bill Maris",
   "claim": "RIA-style asset collection is not venture — venture is a different craft involving concentrated bets of time and capital on entrepreneurs.",
   "stance": "opinion",
   "conviction": 0.85,
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "13:25",
   "quote": "if you're an RIA and you're collecting assets, that is not venture. Venture, as I practice it at least, is a different craft where you are making concentrated bets of your time and capital on entrepreneurs and helping them build a business."
  },
  {
   "holder": "Bill Maris",
   "claim": "Don't bet against computer science — if you apply the right kind of computer science at the right time to the right problem, you will get to the right answers.",
   "stance": "assertion",
   "conviction": 0.9,
   "subjects": [
    "AI infrastructure"
   ],
   "timestamp": "0:15",
   "quote": "If you apply the right kind of computer science at the right time to the right problem, you will get to the right answers. I would not bet against it"
  }
 ],
 "predictions": [
  {
   "holder": "Bill Maris",
   "prediction": "AI will go from its current 'Atari command line stage' to a 'PlayStation 10 stage' within the next five years, driven by infrastructure platforms rather than larger models.",
   "timeframe": "next five years",
   "subjects": [
    "AI infrastructure"
   ],
   "timestamp": "20:48",
   "quote": "We're at the Atari command line stage of AI, and we're going to get to the PlayStation 10 stage in the next five years.",
   "due": "2031-06-09"
  },
  {
   "holder": "Bill Maris",
   "prediction": "If Google chooses to cut token prices by 80%, it will put OpenAI and Anthropic under severe competitive pressure, potentially making their business models unviable.",
   "timeframe": "unspecified",
   "subjects": [
    "Google",
    "OpenAI",
    "Anthropic",
    "token pricing"
   ],
   "timestamp": "13:25",
   "quote": "if you're a company and you can go to Google on Gemini and you can pay 80% less for that basically identical product, why wouldn't you do that? Then the compression and the pressure on those other businesses goes super critical."
  },
  {
   "holder": "Bill Maris",
   "prediction": "The incentive-broken pendulum in venture will eventually swing back, making late-stage sniper investing unsustainable long-term.",
   "timeframe": "unspecified",
   "subjects": [
    "venture capital fund size"
   ],
   "timestamp": "26:45",
   "quote": "And the pendulum will swing back. So I don't think just staying late stage and waiting to sniper at larger companies will be a long term."
  },
  {
   "holder": "Bill Maris",
   "prediction": "The world will change by orders of magnitude in the next 100 years with the advent of AI.",
   "timeframe": "next 100 years",
   "subjects": [
    "AI infrastructure"
   ],
   "timestamp": "0:15",
   "quote": "Think of the change that has happened just in the last 100 years and what's about to happen in the next 100 years with the advent of AI. The world's going to change by orders of magnitude.",
   "due": "2126-06-09"
  }
 ],
 "facts": [
  {
   "statement": "Bill Maris raised $150 million for his new fund Section 32.",
   "subjects": [
    "Section 32",
    "Bill Maris"
   ],
   "value": "$150M",
   "timestamp": "0:02",
   "quote": "The founding CEO of Google Ventures has raised $150 million for his new fund called Section 32",
   "source": "SPEAKER_1"
  },
  {
   "statement": "Section 32 has run six funds, averaging ~$400M in size, all performing top-decile.",
   "subjects": [
    "Section 32"
   ],
   "value": "6 funds, ~$400M avg, all top-decile",
   "timestamp": "0:15",
   "quote": "we've had six funds, we've invested in companies like CrowdStrike and Cohere and Coinbase. And all six of those funds have averaged about 400 million in size and all are performing in their top decile.",
   "source": "Bill Maris"
  },
  {
   "statement": "GV was founded in 2007; Maris estimates its returns at approximately 4.1x for the period 2009–2018.",
   "subjects": [
    "Google Ventures"
   ],
   "value": "~4.1x, 2009-2018",
   "timestamp": "0:15",
   "quote": "over this time period, 2009 to 2018, top quartile VC returns looked like this and top decile looked like this. Using publicly available information, I'm not sharing any non-public proprietary Google information. We would estimate Google Ventures returns at about 4.1x.",
   "source": "Bill Maris"
  },
  {
   "statement": "Top-decile DPI for funds under $750M averaged 476x; for funds over $1B it averaged 242x; funds below $750M represented 95% of top-decile performers.",
   "subjects": [
    "venture capital fund size"
   ],
   "value": "476x (<$750M) vs. 242x (>$1B); 95% of top-decile performers below $750M",
   "timestamp": "0:15",
   "quote": "funds smaller than $750 million, average return of 476X, and funds larger than $1 billion, 242X, funds below $750 million across that time period represented 95% of top decile performers, with discontinuous return compression above $750 million.",
   "source": "Bill Maris"
  },
  {
   "statement": "A $500M fund owning 10% stakes needs $5B of exits to return capital; at 3x target that requires $15B of exit value.",
   "subjects": [
    "venture capital fund size"
   ],
   "value": "$500M fund → $15B exits needed at 3x",
   "timestamp": "0:15",
   "quote": "If you have a $500 million fund, and let's say on average these days, you can own 10% of a company, you need $5 billion of exits to get your money back.",
   "source": "Bill Maris"
  },
  {
   "statement": "Google Ventures was founded in 2007; its first investment in an ex-Google company was Climate Corp (Jason's company), which exited for $1B to Monsanto.",
   "subjects": [
    "Google Ventures",
    "Climate Corp"
   ],
   "value": "$1B exit to Monsanto",
   "timestamp": "12:11",
   "quote": "Climate Corp, a billion-dollar exit to Monsanto.",
   "source": "Bill Maris"
  },
  {
   "statement": "David Sacks's firm Craft Ventures has run four venture funds and two growth funds.",
   "subjects": [
    "David Sacks"
   ],
   "value": "4 venture + 2 growth funds",
   "timestamp": "25:30",
   "quote": "we've done four venture and two growth.",
   "source": "David Sacks"
  },
  {
   "statement": "Maris founded Calico (longevity) while VP of Special Projects at Google; Section 32 is currently invested in New Limit (Blake Byers and Brian Armstrong's longevity company).",
   "subjects": [
    "Calico",
    "New Limit",
    "Bill Maris"
   ],
   "timestamp": "22:06",
   "quote": "I've started Calico and again, it was like fringe science, longevity at the time. Now, we're investors in New Limit, which is Blake Byers and Brian Armstrong's company",
   "source": "Bill Maris"
  }
 ],
 "notable_quotes": [
  {
   "speaker": "Bill Maris",
   "timestamp": "0:15",
   "quote": "small funds outperform large funds. This is simply the math. This is not an opinion I'm trying to convince you of.",
   "why": "The thesis statement of the keynote — delivered as a mathematical conclusion, not an opinion, which is itself a rhetorical move."
  },
  {
   "speaker": "Bill Maris",
   "timestamp": "15:22",
   "quote": "If I were Google, that's what I'd do.",
   "why": "Stripped-down, unhedged verdict on Google using token pricing as a weapon — the most quotable line in the episode."
  },
  {
   "speaker": "Bill Maris",
   "timestamp": "20:48",
   "quote": "We're at the Atari command line stage of AI, and we're going to get to the PlayStation 10 stage in the next five years.",
   "why": "The episode's title-worthy framing — a vivid, specific analogy for AI's current limitations and near-term transformation."
  },
  {
   "speaker": "Bill Maris",
   "timestamp": "13:25",
   "quote": "Venture, as I practice it at least, is a different craft where you are making concentrated bets of your time and capital on entrepreneurs and helping them build a business.",
   "why": "Maris's definition of venture as a craft, not asset management — the philosophical foundation of his small-fund thesis."
  },
  {
   "speaker": "Bill Maris",
   "timestamp": "17:19",
   "quote": "don't say you're doing this for the benefit of humanity and do the other thing.",
   "why": "A punchy critique of companies using public-benefit language to justify keeping IPO value away from retail investors."
  },
  {
   "speaker": "Chamath Palihapitiya",
   "timestamp": "16:06",
   "quote": "That's 100 percent possible. It's 100 percent probable.",
   "why": "Chamath's unequivocal endorsement of the Google-as-price-weapon scenario — doubles down with no hedging."
  }
 ],
 "extracted_by": "agent",
 "prompt_version": "episode-extract@3",
 "_file": "all-in-2026-06-09-bill-maris-how-google-could-crush-ai-competitors-why-small-f.json"
}